Table 2.
Peripheral blood lymphocyte quantification
| CD4:CD8 ratio | CD3CD4 (%) | CD3CD4 106cells/L | CD3CD8 (%) | CD3CD8 106cells/L | CD16CD56 (%) | CD16CD56 106cells/L | |
|---|---|---|---|---|---|---|---|
|
no-fatigue controls (n = 32) |
2.43 (0.97) |
51.1 (8.2) |
990 (376) |
22.9 (5.5) |
440 (198) |
11.7 (6.7) |
210 (99) |
| PI-CFS/ICF (n=24) |
2.05 (0.76) |
50.5 (7.0) |
939 (366) |
27.0 (7.0) |
497 (207) |
7.5 (3.5)** |
130 (54)** |
| PI-CFS (n = 19) |
2.01 (0.77) |
50.3 (6.9) |
912 (296) |
27.5 (7.0)* |
497 (200) |
8.0 (3.6)* |
138 (55)** |
| Fatigue other cause (n=12) |
2.37 (1.14) |
51.9 (8.1) |
1132 (543) |
26.1 (10.4) |
635 (531) |
8.7 (4.6) |
186 (139) |
| Fatigue recovered (n=12) |
1.80 (0.82)* |
46.1 (10.3) |
834 (318) |
28.8 (9.1)* |
545 (225) |
10.6 (9.0) |
203 (188) |
|
no-FGID (n=26) |
2.74 (1.06) |
53.3 (8.6) |
1008 (363) |
21.1 (5.4) |
394 (167) |
11.3 (7.1) |
192 (80) |
| All FGID (n=54) |
1.96 (0.75)** |
48.9 (7.7)* |
958 (415) |
27.6 (7.6)*** |
555 (311)** |
9.1 (5.6) |
176 (129) |
| PI-FGID (n=45) |
2.00 (0.78)** |
49.2 (7.9)* |
949 (418) |
27.1 (7.35)** |
537 (313)* |
8.8 (5.4) |
169 (122) |
| PI-IBS (n=23) |
1.97 (0.91)** |
49.5 (8.8) |
988 (463) |
28.2 (7.1)** |
592 (376)* |
8.1 (5.0)* |
157 (111) |
|
no-FGID/no-fatigue controls (n=23) |
2.65 (1.05) |
52.4 (8.8) |
974 (380) |
21.5 (5.5) |
389 (171) |
11.8 (7.6) |
194 (86) |
| FGID&CFS/ICF(n=23) |
2.01 (0.75)* |
50.2 (7.0) |
923 (366) |
27.3 (6.9)** |
500 (211) |
7.4 (3.5)** |
127 (53)* |
| FGID, no fatigue (n=21) |
1.82 (0.65)** |
46.9 (8.5)* |
924 (356) |
27.9 (7.3)** |
548 (214)** |
11.0 (7.0) |
223 (156) |
| Fatigue other cause w/wo FGID (n=12) | 2.37 (1.14) | 51.9 (8.1) | 1133 (543) | 26.1 (10.4) | 635 (531) | 8.7 (4.6) | 186 (140) |
* p < 0.05 level compared to the control group (in italics) in each categorization.
** Significant at p<0.01 level compared to the control group (in italics) in its categorization.
*** Significant at p<0.001 level compared to the control group (in italics) in its categorization.
CD4:CD8 T-cells ratio, CD4 and CD8 T-cell subsets, CD16CD56 natural killer cells percentages and concentrations by analysis categorizations and relevant subgroups. All values are given as mean (SD). Data for the subgroups of PI-CFS, PI-FGID and PI-IBS are also given (indented).